Thomas Beach
Neuropathology · Sun City, AZNPI 1417292152
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Roche Molecular Systems, Inc. at 56.1% of the total. Reporting peaked in 2021 at $1,500 and has fallen 90.7% since, to $139 in 2025.
Across 5 payments — averaging $534.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Molecular Systems, Inc.$2K
- Biogen$1K
- Lantheus Medical Imaging, Inc.$139
- AbbVie$31
Across 9 payments — averaging $137,906 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$667K
- GSK$343K
- Avid Radiopharmaceuticals, Inc.$193K
- F. Hoffmann-la Roche AG$38K
What the payments were for
- Consulting fees$1,00237%
- Speaking & faculty fees$1,25047%
- Food & beverage$1706%
- Education$2509%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Molecular Systems, Inc. | 2 | $1,500 |
| Biogen | 1 | $1,002 |
| Lantheus Medical Imaging, Inc. | 1 | $139 |
| AbbVie | 1 | $31 |
How this compares
Too few neuropathology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Other neuropathology in Sun City
- Naomi RanceTucson$6K
- Ahmed GilaniPhoenix$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.